Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Arcus Biosciences, Inc. (RCUS) vs Zai Lab Limited Unsponsored ADR (ZLAB)

Arcus Biosciences, Inc. and Zai Lab Limited Unsponsored ADR are both Biotechnology companies. Arcus Biosciences, Inc. is the larger, with a market value of $3.2B against $2.9B — 1.1× the size. Zai Lab Limited Unsponsored ADR grew revenue faster over the last twelve months: 5.10% against −55.3%. Zai Lab Limited Unsponsored ADR has the higher net margin (−41.9% vs −393.2%) and the lower return on invested capital (−129.3% vs 0.00%). Across the 18 metrics below, Zai Lab Limited Unsponsored ADR leads on 13 and Arcus Biosciences, Inc. on 5.

Valuation

Metric RCUS ZLAB Biotechnology median
P/E n/m n/m 7.88
P/S 26.65 6.21 11.47
P/B 6.72 4.60 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 21.52 5.14 10.73
Earnings yield (15.77%) (6.85%) (28.84%)
Free cash flow yield (15.26%) (5.82%) (23.03%)

Profitability

Metric RCUS ZLAB Biotechnology median
Gross margin 100.00% 56.47% 65.16%
Operating margin (415.38%) (58.74%) 0.00%
Net margin (393.16%) (41.86%) 0.00%
Free cash flow margin (405.13%) (36.13%) 0.00%
Return on equity (90.82%) (26.91%) (57.72%)
Return on assets (46.02%) (16.81%) (49.22%)
Return on invested capital 0.00% (129.34%) 0.00%

Growth

Metric RCUS ZLAB Biotechnology median
Revenue growth (TTM) (55.34%) 5.10% 5.64%
EPS growth (last fiscal year) (4.78%) 38.46% —
Revenue growth, 5-year CAGR 25.93% 56.54% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RCUS ZLAB Biotechnology median
Debt to equity 0.22 0.39 0.00
Current ratio 3.82 2.13 4.73
Net debt to EBITDA 2.27 2.66 0.96

Dividend

Metric RCUS ZLAB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric RCUS ZLAB Biotechnology median
Market cap 3.19b 2.85b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack